

Struggling to find Aurovela 1/20 21 Day at your pharmacy? Learn why this birth control pill is hard to find in 2026 and what you can do about it.
You've been taking Aurovela 1/20 21 Day for months — maybe years — and suddenly your pharmacy can't fill your prescription. You call around, and nobody seems to have it. Sound familiar?
You're not imagining things. Many patients across the country have been struggling to find Aurovela 1/20 21 Day in stock at their local pharmacies. In this article, we'll explain what Aurovela 1/20 21 Day is, why it's been difficult to find, and — most importantly — what you can do about it right now.
Aurovela 1/20 21 Day is a combination oral contraceptive (birth control pill) made by Aurobindo Pharma. Each tablet contains two hormones: Norethindrone Acetate 1 mg (a progestin) and Ethinyl Estradiol 20 mcg (an estrogen).
It's a generic equivalent of the well-known brand Loestrin 1/20, and it works the same way as other popular generics like Junel 1/20, Microgestin 1/20, and Blisovi Fe 1/20. The "21 Day" part means the pack contains 21 active hormone pills. You take one pill every day for 21 days, then take a 7-day break before starting your next pack.
Doctors prescribe Aurovela 1/20 21 Day primarily to prevent pregnancy, but it's also used to help regulate menstrual cycles, treat moderate acne, and manage symptoms of conditions like endometriosis and PCOS.
There's no single reason why Aurovela 1/20 21 Day has been difficult to locate. It's a combination of factors that have created a perfect storm for patients:
The generic oral contraceptive market has gone through significant consolidation over the past few years. Fewer manufacturers are making the same products, which means if one company experiences a production slowdown, there's less backup supply to go around. Aurobindo Pharma is one of the largest generic manufacturers in the world, but even large companies face production challenges.
The pharmaceutical supply chain has faced ongoing disruptions since the pandemic era. Raw material shortages, shipping delays, and quality control issues can all slow down production. For a daily medication like birth control, even a small hiccup in supply can quickly lead to empty shelves at pharmacies.
Pharmacies — especially large chains — manage inventory based on demand forecasts and profit margins. If a pharmacy expects low demand for a specific generic brand, they may not keep it consistently in stock. This is especially true for medications where multiple generics exist (like Norethindrone Acetate/Ethinyl Estradiol 1/20), because the pharmacy might stock a different brand instead.
Your insurance plan may prefer a different generic brand over Aurovela. When insurance companies negotiate deals with certain manufacturers, pharmacies tend to stock whatever brand the major insurance plans cover. If your plan recently switched preferred generics, your pharmacy may have stopped ordering Aurovela 1/20 altogether.
The good news is you have options. Here are practical steps to help you get your birth control without interruption:
Instead of calling pharmacy after pharmacy, use Medfinder to search for Aurovela 1/20 21 Day availability near you. Medfinder checks real-time stock at pharmacies in your area so you can find who actually has it on the shelf.
If your regular pharmacy doesn't have Aurovela 1/20 in stock, ask them to place a special order from their distributor. Many pharmacies can get it within 1-2 business days. Be sure to ask them to confirm availability before you wait.
Independent and locally owned pharmacies often have more flexibility in what they stock and can sometimes source medications that chain pharmacies can't. They may also be more willing to work with you on finding your specific brand. Learn more in our guide on how to find Aurovela 1/20 21 Day in stock near you.
If you absolutely can't find Aurovela 1/20 21 Day, your doctor can prescribe a therapeutically equivalent alternative. Medications like Junel 1/20, Microgestin 1/20, and Blisovi Fe 1/20 contain the exact same active ingredients at the same doses. Check out our full breakdown of alternatives to Aurovela 1/20 21 Day.
Aurovela Fe 1/20 is the 28-day version of the same medication. It contains the same 21 active tablets plus 7 inactive iron (ferrous fumarate) tablets. The hormones are identical — the only difference is the reminder pills. If the 21-day version is out of stock, the Fe version may be easier to find.
Without insurance, Aurovela 1/20 21 Day typically costs between $30 and $50 per pack at retail pharmacies. However, with a discount coupon from services like SingleCare or GoodRx, you can often pay as little as $8 to $15 per pack. Most insurance plans cover generic oral contraceptives with a $0 copay under the ACA contraceptive mandate. For more ways to save, read our guide on how to save money on Aurovela 1/20 21 Day.
Finding your birth control shouldn't feel like a scavenger hunt, but for many patients taking Aurovela 1/20 21 Day, that's exactly what it's become. The combination of manufacturing consolidation, supply chain issues, and pharmacy stocking decisions has made this medication harder to find — but not impossible.
Start by using Medfinder to locate pharmacies with Aurovela 1/20 21 Day in stock near you. If that doesn't work, talk to your doctor about equivalent alternatives. The most important thing is that you don't go without your birth control — gaps in oral contraceptive use can increase your risk of unintended pregnancy.
For more information about this medication, check out our complete guide on what Aurovela 1/20 21 Day is and how it works.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.